 |
|
 |
Özgeçmiş |
 |
|
|
Hematoloji |
|
|
|
Hematolojik Onkoloji |
|
|
|
Aferez |
|
|
|
Kök Hücre Nakli |
|
|
|
Sorularınız |
|
|
|
Seminerler |
|
|
|
Ders 2008 |
|
|
|
Homer |
|
|
|
Linkler |
|
|
|
Son Gelişmeler |
|
|
|
Halk İçin Hematoloji |
|
|
|
|
|
Aktiviteler |
|
|
 |
|
|
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse 100 (2): 406-414 JUL 15 2002
Wolff D, Steiner B, Stilgenbauer S, et al. Treatment with campath-1H for relapsed chronic lymphocytic leukemia after allogeneic peripheral blood stem cell transplantation does not abrogate the development of chronic GVHD Lang P, Klingebiel T, Bader P, et al. Transplantation of highly purified peripheral-blood CD34(+) progenitor cells from related and unrelated donors in children with nonmalignant diseases Spiryda LB, Laufer MR, Soiffer RJ, et al. Graft-versus-host disease of the vulva and/or vagina: Diagnosis and treatment Pinton PC, Porta F, Izzi T, et al. Prospects for ultraviolet A1 phototherapy as a treatment for chronic cutaneous graft-versus-host disease Corradini P, Cavo M, Lokhorst H, et al. Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma Lee JH, Lee JH, Choi SJ, et al. Graft-versus-host disease (GVHD)-specific survival and duration of systemic immunosuppressive treatment in patients who developed chronic GVHD following allogeneic haematopoietic cell transplantation Akpek G, Lee SJ, Flowers ME, et al. Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study Mohty M, Bilger K, Jourdan E, et al. Higher doses of CD34+peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation Socie G, Salooja N, Cohen A, et al. Nonmalignant late effects after allogeneic stem cell transplantation Lee SJ, Vogelsang G, Flowers MED Chronic graft-versus-host disease Mengarelli A, Iori AP, Romano A, et al. One-year cyclosporine prophylaxis reduces the risk of developing extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation Devine SM, Adkins DR, Khoury H, et al. Recent advances in allogeneic hematopoietic stem-cell transplantation Lee SJ, Cook EF, Soiffer R, et al. Development and validation of a scale to measure symptoms of chronic graft-versus-host disease
88 (6): 2362-2364 SEP 15 1996
Arslan O, Coskun HS, Arat M, et al. Allogeneic peripheral blood stem cell transplantation for standard risk leukemia: experience of Ibni Sina Hospital Miller JS, Prosper F, McCullar V Natural killer (NK) cells are functionally abnormal and NK cell progenitors are diminished in granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cell collections
Validation of the EBMT risk score for recipients of allogeneic hematopoetic stem cell transplants for chronic myeloid leukemia (CML). 98 (11): 1470 Part 1 NOV 16 2001
Goldman JM Therapeutic strategies for chronic myeloid leukemia in the chronic (stable) phase Copelan EA To the editor: Treatment options in chronic myelogenous leukemia HLA-DR FREQUENCY IN TURKISH APLASTIC-ANEMIA PATIENTS AND THE IMPACT OF HLA-DR2 POSITIVITY IN RESPONSE RATE IN PATIENTS RECEIVING IMMUNOSUPPRESSIVE THERAPY 86 (5): 2055-2055 SEP 1 1995
Peng J, Liu CF, Zhu KL, et al. The TNF2 allele is a risk factor to severe aplastic anemia independent of HLA-DR Oguz FS, Yalman N, Diler AS, et al. HLA-DRB1*15 and pediatric aplastic anemia Kapustin SI, Popova TI, Lyshchov AA, et al. HLA-DR4-Ala74 ss is associated with risk and poor outcome of severe aplastic anemia Ihan O, Beksac M, Arslan O, et al. HLA DR2: A predictive marker in response to cyclosporine therapy in aplastic anemia
Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: A report from the European blood and marrow transplant (EBMT) severe aplastic anaemia working party 93 (7): 2191-2195 APR 1 1999
Giannakoulas NC, Karakantza M, Theodorou GL, et al. Clinical relevance of balance between type 1 and type 2 immune responses of lymphocyte subpopulations in aplastic anaemia patients Marsh JCW, Ball SE, Darbyshire P, et al. Guidelines for the diagnosis and management of acquired aplastic anaemia Maciejewski JP, Sloand EM, Nunez O, et al. Recombinant humanized anti-IL-2 receptor antibody (daclizumab) produces responses in patients with moderate aplastic anemia Michallet MC, Saltel F, Preville X, et al. Cathepsin-B-dependent apoptosis triggered by antithymocyte globulins: a novel mechanism of T-cell depletion
Antithymocyte globulin (ATG)-based therapy in patients with myelodysplastic syndromes Ahn MJ, Choi JH, Lee YY, et al. Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: Multicenter trial Dubey S, Nityanand S Involvement of Fas and TNF pathways in the induction of apoptosis of T cells by antithymocyte globulin Flynn J, Cox CV, Rizzo S, et al. Direct binding of antithymoctye globulin to haemopoietic progenitor cells in aplastic anaemia Sleijfer S, Lugtenburg PJ Aplastic anaemia: a review Takabayashi M, Sakai R, Sakamoto H, et al. Merkel cell carcinoma developing after antithymocyte globulin and cyclosporine therapy for aplastic anemia Kahn Q, Ellis RJ, Skikne BS, et al. A retrospective analysis of long-term survival in severe aplastic anemia patients treated with allogeneic bone marrow transplantation or immunosuppressive therapy with antithymocyte globulin and cyclosporin A at a single institution Frickhofen N, Heimpel H, Kaltwasser JP, et al. Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia Gluckman E, Rokicka-Milewska R, Hann I, et al. Results and follow-up of a phase III randomized study of recombinant human-granulocyte stimulating factor as support for immunosuppressive therapy in patients with severe aplastic anaemia Zonder JA, Keating M, Schiffer CA Chronic lymphocytic leukemia presenting in association with aplastic anemia Matsuda A, Kishimoto K, Yoshida K, et al. Long-term follow-up of patients with aplastic anemia and refractory anemia responding to combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin Bozkaya H, Yurdaydin C, Toruner M, et al. Remission of severe aplastic anemia associated with hepatitis B virus infection after viral clearance - Potential role of lamivudine Dubey S, Srivastava A, Nityanand S Induction of apoptosis of peripheral blood mononuclear cells by antithymocyte globulin (ATG) in aplastic anemia: an in vivo and in vitro study Ishiyama K, Karasawa M, Miyawaki S, et al. Aplastic anaemia with 13q-: a benign subset of bone marrow failure responsive to immunosuppressive therapy Wolff SN Mini-review - Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation Young NS Immunosuppressive treatment of acquired aplastic anemia and immune-mediated bone marrow failure syndromes Dufour C, Corcione A, Svahn J, et al. Interferon gamma and tumour necrosis factor alpha are overexpressed in bone marrow T lymphocytes from paediatric patients with aplastic anaemia Kuriyama K, Todo S, Ikushima S, et al. Risk factors for cytomegalovirus retinitis following bone marrow transplantation from unrelated donors in patients with severe aplastic anemia or myelodysplasia Fujimaki S, Harigae H, Sugawara T, et al. Decreased expression of transcription factor GATA-2 in haematopoietic stem cells in patients with aplastic anaemia Lee JJ, Kook H, Chung IJ, et al. Telomere length changes in patients with aplastic anaemia Preville X, Flacher M, LeMauff B, et al. Mechanisms involved in antithymocyte globulin immuno suppressive activity in a nonhuman primate model Killick SB, Cox CV, Marsh JCW, et al. Mechanisms of bone marrow progenitor cell apoptosis in aplastic anaemia and the effect of anti-thymocyte globulin: examination of the role of the Fas-Fas-L interaction Preville X, Nicolas L, Flacher M, et al. A quantitative flow cytometry assay for the preclinical testing and pharmacological monitoring of rabbit antilymphocyte globulins (rATG) Killick SB, Marsh JCW Aplastic anaemia: Management Kojima S, Nakao S, Tomonaga M, et al. Consensus conference on the treatment of aplastic anemia Marsh JCW Results of immunosuppression in aplastic anaemia Bacigalupo A, Bruno B, Saracco P, et al. Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients Frickhofen N, Rosenfeld SJ Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine Bacigalupo A, Brand R, Oneto R, et al. Treatment of acquired severe aplastic anemia: Bone marrow transplantation compared with immunosuppressive therapy - The European Group for Blood and Marrow Transplantation Experience Reddy V, Khan S, Wingard JR, et al. Treatment results in aplastic anemia trials need to be analyzed separately for pediatric and adult populations A randomized trial of assessment of efficacy of leukapheresis volumes, 8 liters vs 12 liters 29 (11): 893-897 JUN 2002
Sohn SK, Kim JG, Chae YS, et al. Large-volume leukapheresis using femoral venous access for harvesting peripheral blood stem cells with the fenwal CS 3000 plus from normal healthy donors: Predictors of CD34+ cell yield and collection efficiency J CLIN APHERESIS 18 (1): 10-15 2003
29: O239 Suppl. 2 MAR 2002
Beksac M, Celebi H, Sargin D, et al. Role of pretransplant interferon-alpha(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): results from three Turkish transplant centers Gratwohl A Prognostic factors in chronic myeloid leukemia: Allografting
Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation 27 (5): 499-505 MAR 2001
Appelbaum FR Use of granulocyte colony-stimulating factor following hematopoietic cell transplantation: Does haste make waste?
Ho VT, Mirza NQ, del Junco D, et al. The effect of hematopoietic growth factors on the risk of graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: a meta-analysis Chakraborty A, Hentzen ER, Seo SM, et al. Granulocyte colony-stimulating factor promotes adhesion of neutrophils A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies 25 (7): 697-703 APR 2000
Demirer T, Uysal VA, Ayli M, et al. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation Demirer T, Ayli M, Dagli M, et al. The effect of post-transplant spironolactone on daily potassium requirements in patients undergoing autologous stem cell transplantation Demirer T, Ilhan O, Ayli M, et al. Monitoring of peripheral blood CD34+cell counts on the first day of apheresis is highly predictive for efficient CD34+cell yield Demirer T, Ayli M, Dagli M, et al. Influence of post-transplant recombinant human granulocyte colony-stimulating factor administration on peritransplant morbidity in patients undergoing autologous stem cell transplantation Demirer T, Ayli M, Ozcan M, et al. Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of different doses of rhG-CSF Allogeneic peripheral blood stem cell transplantation for standard risk leukemia: experience of Ibni Sina Hospital 25 (12): 1229-1232 JUN 2000
Cutler C, Giri S, Jeyapalan S, et al. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: A meta-analysis -
Autoimmune thrombocytopenia in a patient with small cell lung cancer developing after chemotherapy and resolving following autologous peripheral blood stem cell transplantation 24 (3): 335-337 AUG 1999
Morey M, Bargay J, Galmes A, et al. Remission of longlasting autoimmune thrombocytopenic purpura after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia Wong ASC, Yoon KH Paraneoplastic Raynaud phenomenon and idiopathic thrombocytopenic purpura in non-small-cell lung cancer Ustun C, Dainer P, Hendricks L, et al. Association of breast cancer and immune thrombocytopenic purpura Cohen Y, Polliack A, Nagler A Treatment of refractory autoimmune diseases with ablative immunotherapy using monoclonal antibodies and/or high dose chemotherapy with hematopoietic stem cell support Huhn RD, Fogarty PF, Nakamura R, et al. High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia Burt RK, Slavin S, Burns WH, et al. Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: Getting closer to a cure? Bingham SJ, Snowden J, Morgan G, et al. High dose immunosuppressive therapy and stem cell transplantation in autoimmune and inflammatory diseases Zaydan MA, Turner C, Miller AM Resolution of chronic idiopathic thrombocytopenia purpura following syngeneic peripheral blood progenitor transplant Burt RK, Slavin S, Burns WH, et al. Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure? Oyama Y, Papadopoulos EB, Miranda M, et al. Allogeneic stem cell transplantation for Evans syndrome Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia 21 (11): 1159-1161 JUN 1998
DiGiovanna JJ, Robinson-Bostom L Ichthyosis - Etiology, diagnosis, and management Sanli H, Ekmekci P, Kusak F, et al. Hyperkeratosis of the nipple associated with chronic graft versus host disease after allogeneic haematopoietic cell transplantation Canninga-van Dijk MR, Sanders CJ, Verdonck LF, et al. Differential diagnosis of skin lesions after allogeneic haematopoietic stem cell transplantation Au WY, Ma SY, Yeung CK, et al. A patient with congenital ichthyosis Hystrix (disseminated congenital naevus) and acute lymphoblastic leukaemia Tolar J, Kravitz G, Walker K, et al. Acute polyosteal osteomyelitis in a patient with congenital ichthyosis and acute lymphoblastic leukemia Hepatitis B virus infection in allogeneic bone marrow transplantation 20 (4): 289-296 AUG 1997
George B, Mathews V, Srivastava A, et al. Infections among allogeneic bone marrow transplant recipients in India Idilman R, Ustun C, Karayaicin S, et al. Hepatitis B virus vaccination of recipients and donors of allogeneic peripheral blood stem cell transplantation Ma SY, Au WY, Ng IOL, et al. Role of liver biopsy in the management of liver dysfunction after hematopoietic stem-cell transplantation in a hepatitis B virus-prevalent patient population Ma SY, Lau GKK, Cheng VCC, et al. Hepatitis B reactivation in patients positive for hepatitis B surface antigen undergoing autologous hematopoietic cell transplantation Lindemann M, Barsegian V, Runde V, et al. Transfer of humoral and cellular hepatitis B immunity by allogeneic hematopoietic cell transplantation Gigliotti AR, Fioredda F, Giacchino R Hepatitis B and C infection in children undergoing chemotherapy or bone marrow transplantation Rossi G Prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with hemato-oncological neoplasias treated with chemotherapy Kupeli S, Ozen H, Uckan D, et al. Changes in hepatitis B virus serology in bone marrow transplanted children Lau GKK, He ML, Fong DYT, et al. Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantation Chen PM, Yao NS, Wu CM, et al. Detection of reactivation and genetic mutations of the hepatitis B virus in patients with chronic hepatitis B infections receiving hematopoietic stem cell transplantation Hamaguchi M, Yamada H, Gondo H, et al. Retrospective study on the impact of hepatitis B and hepatitis C virus infection on hematopoietic stem cell transplantation in Japan Lau GKK, Leung YH, Fong DYT, et al. High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation Hashino S, Takahata M, Nozawa A, et al. Successful allogeneic bone marrow transplantation from an HBV-positive donor into an HBV-positive recipient using lamivudine Sitruk V, Fain O, Gordien E, et al. Chemotherapy and immunosuppression in patients with hepatitis B or C Luo XR, Yan AW, Liang R, et al. Hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy - pathogenesis and management Lau GKK Use of immunomodulatory therapy (other than interferon) for the treatment of chronic hepatitis B virus infection Nordbo SA, Skaug K, Holter E, et al. Reactivation of hepatitis B virus infection in an anti-HBc and anti-HBs positive patient after allogeneic bone marrow transplantation Ustun C, Idilman R, Gurman G, et al. Hematopoietic stem cell transplantation from non-replicative hepatitis B virus carriers is safe Lau GKK, Lee CK, Liang R Hepatitis B virus infection and bone marrow transplantation Strasser SI, McDonald GB Hepatitis viruses and hematopoietic cell transplantation: A guide to patient and donor management Eosinophilia after allogeneic bone marrow transplantation using busulfan and cyclophosphamide conditioning regimen 18 (1): 261-261 JUL 1996
Rumi C, Rutella S, Bonini S, et al. Immunophenotypic profile of peripheral blood eosinophils in acute graft-vs.-host disease ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION AS A 2ND TRANSPLANT FOR SEVERE APLASTIC-ANEMIA 15 (3): 485-486 MAR 1995
Wan LP, Yan SK, Wang C, et al. Allogeneic peripheral blood stem cell transplantation in the treatment of severe aplastic anemia and severe infection Chung IJ, Lee JJ, Park MR, et al. Allogeneic peripheral blood stem cell rescue of late graft failure after bone marrow transplantation in patients with aplastic anemia Gurman G, Celebi H, Ustun C, et al. Allogeneic peripheral blood stem cell transplantation for severe aplastic anemia Deane M, Koh M, Foroni L, et al. FLAG-idarubicin and allogeneic stem cell transplantation for Ph-positive ALL beyond first remission Tanabe J, Maruta A, Koharazawa H, et al. Allogeneic peripheral blood progenitor cell transplantation conditioned with anti-thymocyte globulin for treatment of graft failure after allogeneic bone marrow transplantation Arslan O, Seferoglu A, Gurman G, et al. Resistant graft failure overcome with allogeneic peripheral blood plus bone marrow stem cells Koc H, Gurman G, Arslan O, et al. Allogeneic peripheral blood stem cell transplantation: Is there an increased risk of graft vs host disease in leukemia patients? Hsu HC, Tsai WH, Lin JS, et al. Primary transplantation of allogeneic peripheral blood stem cell for severe aplastic anemia Redei I, Waller EK, Holland HK, et al. Successful engraftment after primary graft failure in aplastic anemia using G-CSF mobilized peripheral stem cell transfusions Atkinson K, Fay K, NivisonSmith I, et al. Lenograstim administration to HLA-identical donor-recipient pairs to accelerate marrow recovery post-transplant Koc H, Gurman G, Arslan O, et al. Is there an increased risk of graft-versus-host disease after allogeneic peripheral blood stem cell transplantation? Bensinger WI, Clift RA, Anasetti C, et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor Bensinger WI, Appelbaum FA, Demirer T, et al. Transplantation of allogeneic peripheral blood stem cells
Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of different doses of rhG-CSF 116 (2): 468-474 FEB 2002
Bedi R, Kumar L, Kochupillai V Autologous peripheral blood stem cell transplantation: Predictors for haematopoietic reconstitution Demirer T CD34+cells in hematopoietic stem cell transplantation Kessinger A, Sharp JG The whys and hows of hematopoietic progenitor and stem cell mobilization Takeyama K, Ogura M, Morishima Y, et al. A dose-finding study of glycosylated G-CSF (Lenograstim) combined with CHOP therapy for stem cell mobilization in patients with non-Hodgkin's lymphoma Perez-Duenas B, Alcorta I, Estella J, et al. Safety and efficacy of high-dose G-CSF (24 mu g/kg) alone for PBSC mobilization in children Circulating CD44 and intercellular adhesion molecule-1 levels in low grade non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia patients during interferon-alpha-2a treatment 89 (7): 1474-1481 OCT 1 2000
Naor D, Nedvetzki S, Golan I, et al. CD44 in cancer Wollina U, Mentzel T, Graefe T Large B-cell lymphoma of the leg - Complete remission with perilesional interferon alpha Pena AS What have we learned from the biological therapies in ulcerative colitis? RELEVANCE OF SERUM G-CSF LEVELS IN BONE-MARROW TRANSPLANTATION PATIENTS 22 (6): 480-481 JUN 1994
de Vries P, Singer JW Lisofylline suppresses ex vivo release by murine spleen cells of hematopoietic inhibitors induced by cancer chemotherapeutic agents Saito K, Nakamura Y, Waga K, et al. Mature and immature myeloid cells decrease the granulocyte colony-stimulating factor level by absorption of granulocyte colony-stimulating factor Ozcan M, Beksac M Is there a relationship between G-CSF response to conditioning regimen and engraftment after bone marrow transplantation? Sica S, Rutella S, Testa U, et al. Endogenous cytokine levels after immunoselected CD34(+) peripheral blood progenitor cell transplantation Resistant graft failure overcome with allogeneic peripheral blood plus bone marrow stem cells 29 (1): 47-50 1998
Wolff SN Mini-review - Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation Incidence of Tuberculosis after bone marrow transplantation in a single center from Turkey 29 (1): 59-62 1998
Yuldasheva NE, Karachunsky MA, Pivnik AV Approach to tuberculosis diagnosis in patients with hemoblastosis Yuen KY, Woo PCY Tuberculosis in blood and marrow transplant recipients George B, Mathews V, Srivastava V, et al. Tuberculosis among allogeneic bone marrow transplant recipients in India Kindler T, Schindel C, Brass U, et al. Fatal sepsis due to Mycobacterium tuberculosis after allogeneic bone marrow transplantation Budak-Alpdogan T, Tangun Y, Kalayoglu-Besisik S, et al. The frequency of tuberculosis in adult allogeneic stem cell transplant recipients in Turkey de la Camara R, Martino R, Granados E, et al. Tuberculosis after hematopoietic stem cell transplantation: incidence, clinical characteristics and outcome Serum erythropoietin levels in patients with leukemia on cytostatic treatment 29 (2): 133-137 1998
Bruserud O, Foss B, Petersen H Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L) Padro T, Berdel WE, Buchner T, et al. Angiogenesis and anemia in acute myeloid leukemia
Administration of MINE protocol in untreated patients with intermediate and high grade non-Hodgkin's lymphoma 28 (4): 207-213 1997
Armitage JO The role of mitoxantrone in non-Hodgkin's lymphoma Incidence of graft vs host disease in allogeneic bone marrow transplantation in a single center study from Turkey 39 (3): 133-136 JUN 1997
Tsang KS, Wong APY, Cheung MS, et al. Implication of maternal-cell contamination in the clinical banking of umbilical cord blood
Allogeneic peripheral blood stem cell transplantation in acute non-lymphoblastic leukemia 16 (4): 155-162 DEC 1998
Gurman G, Celebi H, Ustun C, et al. Allogeneic peripheral blood stem cell transplantation for severe aplastic anemia Nivison-Smith I, Bradstock KF, Szer J, et al. Allogeneic haemopoietic cell transplants in Australia, 1996 - A multicentre retrospective comparison of the use of peripheral blood stem cells with bone marrow Arslan O, Coskun HS, Arat M, et al. Allogeneic peripheral blood stem cell transplantation for standard risk leukemia: experience of Ibni Sina Hospital A case report of a patient who has pure red cell aplasia and rheumatoid arthritis 66 (4): 505-512 DEC 1997
Ustun C, Kallab A, Loebl D, et al. Rheumatoid arthritis and immune thrombocytopenia: A report of two cases Young NS Immunosuppressive treatment of acquired aplastic anemia and immune-mediated bone marrow failure syndromes Febrile neutropenia in a bone marrow transplantation unit 8 (2): 127-130 MAR 1997
Celebi H, Akan H, Akcaglayan E, et al. Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies Hemorrhagic cystitis as a complication of bone marrow transplantation 9 (1): 56-61 FEB 1997
Priftakis P, Bogdanovic G, Kokhaei P, et al. BK virus (BKV) quantification in urine samples of bone marrow transplanted patients is helpful for diagnosis of hemorrhagic cystitis, although wide individual variations exist Deliliers GL, Annaloro C, Deliliers DL Complications of autologous hematopoietic stem cell transplantation Ordemann R, Naumann R, Geissler G, et al. Encouraging results in the treatment of haemorrhagic cystitis with estrogen - report of 10 cases and review of the literature
Allogeneic peripheral blood stem cell transplantation: Is there an increased risk of graft vs host disease in leukemia patients? 9 (5): 371-376 OCT 1997
Allogeneic peripheral blood stem cell transplantation in acute non-lymphoblastic leukemia
CD41+and CD42+hematopoietic progenitor cells may predict platelet engraftment after allogeneic peripheral blood stem cell transplantation 16 (2): 67-73 2001
Tabbara IA, Kairouz S, Nahleh Z, et al. Current concepts in allogeneic hematopoietic stem cell transplantation Marczin N, El-Habashi N, Hoare GS, et al. Antioxidants in myocardial ischemia-reperfusion injury: therapeutic potential and basic mechanisms
Heimfeld S HLA-identical stem cell transplantation: is there an optimal CD34 cell dose? Baines M, Shenkin A Use of antioxidants in surgery: a measure to reduce postoperative complications
Hematopoietic stem cell transplantation from non-replicative hepatitis B virus carriers is safe 31 (2): 202-209 AUG 1999
Idilman R, Ustun C, Karayaicin S, et al. Hepatitis B virus vaccination of recipients and donors of allogeneic peripheral blood stem cell transplantation Idilman R, Colantoni A, De Maria N, et al. Impaired antibody response rates after high dose short interval hepatitis B virus vaccination of immunosuppressed individuals Hamaguchi M, Yamada H, Gondo H, et al. Retrospective study on the impact of hepatitis B and hepatitis C virus infection on hematopoietic stem cell transplantation in Japan TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE (TDT) POSITIVITY IN ACUTE NONLYMPHOBLASTIC LEUKEMIA 8 (6): 1067-1067 JUN 1994
SASAKI R, MIURA Y DETECTION OF TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE (TDT) IN NONLYMPHOCYTIC LEUKEMIA BY IMMUNOFLUORESCENT (IF) ASSAY THE CLINICAL CORRELATIONS OF SERUM TUMOR-NECROSIS-FACTOR-ALPHA IN ACUTE LEUKEMIAS - A PREDICTOR OF RESPONSE AND RELAPSE 7 (11): 1773-1776 NOV 1993
Nishimura N, Harada-Shiba M, Tajima S, et al. Acquisition of secretion of transforming growth factor-beta 1 leads to autonomous suppression of scavenger receptor activity in a monocyte-macrophage cell line, THP-1 Denecker NEJ, Kullberg BJ, Drenth JPH, et al. Regulation of the production of pro-inflammatory cytokines and antagonists during chemotherapy-induced neutropenia in patients with haematological malignancies
An unusual presentation of plasma cell dyscrasias: Cardiac tamponade due to myelomatous infiltration 43 (1): 145-148 JAN 2002
Burkhardt O, Dickgreber NJ, Buhling F, et al. Diagnosis of multiple myeloma by demonstrating plasma cells in bronchoalveolor lavage Lack of prognostic value of CD34 in adult AML 23 (1-2): 185-186 SEP 1996
van Stijn A, van der Pol MA, Kok A, et al. Differences between the CD34(+) and CD34(-) blast compartments in apoptosis resistance in acute myeloid leukemia Basso G, Lanza F, Orfao A, et al. Clinical and biological significance of CD34 expression in acute leukemia Kanda Y, Hamaki T, Yamamoto R, et al. The clinical significance of CD34 expression in response to therapy of patients with acute myeloid leukemia - An overview of 2483 patients from 22 studies Giles FJ, Kantarjian HM, Cortes J, et al. Multidrug resistance protein expression in chronic myeloid leukemia - Associations and significance
Randomised unicenter trial for comparison of three regimens in de novo adult acute nonlymphoblastic leukaemia 15 (3): 183-190 SEP 1998
Ustun C, Beksac M, Dalva K, et al. In vivo use of all-trans retinoic acid prior to induction chemotherapy improves complete remission rate and increases rhodamine 123 uptake in patients with de novo acute myeloid leukemia P53 CODON-213 (A-G) POLYMORPHISM IN A TURKISH POPULATION 12 (5): 499-501 SEP-OCT 1995
Mueller J, Gansauge S, Mattfeldt T P53 mutation but not p16/MTS1 mutation occurs in intraductal papillary mucinous tumors of the pancreas Hillebrandt S, Streffer C, Demidchik EP, et al. Polymorphisms in the p53 gene in thyroid tumours and blood samples of children from areas in Belarus
Allogeneic peripheral blood stem cell transplantation for severe aplastic anemia 5 (1): 54-57 FEB 2001
Torres HA, Bodey GP, Rolston KVI, et al. Infections in patients with aplastic anemia - experience at a tertiary care cancer center Wan LP, Yan SK, Wang C, et al. Allogeneic peripheral blood stem cell transplantation in the treatment of severe aplastic anemia and severe infection National survey of hemapheresis practice in Turkey (1998) 22 (3): 195-201 JUN 2000
Norda R, Stegmayr BG Therapeutic apheresis in Sweden: update of epidemiology and adverse events Stegmayr B, Korach JM, Norda R, et al. Is there a need for a national or a global apheresis registry? Taraldsrud E, Kvalheim G, Jorstad S, et al. A survey of therapeutic hemapheresis in Norway year 2000 Schettler V, Wieland E, Armstrong VW, et al. First steps toward the establishment of a German low-density lipoprotein-apheresis registry: Recommendations for the indication and for quality management Pelus LM, Horowitz D, Cooper SC, et al. Peripheral blood stem cell mobilization - A role for CXC chemokines Chong HT, Tan CT Plasmapheresis in the University of Malaya Medical Centre, Malaysia Norda R, Berseus O, Stegmayr B Adverse events and problems in therapeutic hemapheresis. A report from the Swedish registry
The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation 20 (1): 69-71 FEB 1999
Heimfeld S HLA-identical stem cell transplantation: is there an optimal CD34 cell dose? Hunt CJ, Armitage SE, Pegg DE Cryopreservation of umbilical cord blood: 2. Tolerance of CD34(+) cells to multimolar dimethyl sulphoxide and the effect of cooling rate on recovery after freezing and thawing Waller EK, Rosenthal H, Lonial S DC2 effect on survival following allogeneic bone marrow transplantation Waller EK, Rosenthal H, Jones TW, et al. Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation Cutler C, Antin JH Peripheral blood stem cells for allogeneic transplantation: A review Arslan O, Akan H, Arat M, et al. Soluble adhesion molecules (sICAM-1, sL-Selectin, sE-Selectin, sCD44) in healthy allogenic peripheral stem-cell donors primed with recombinant C-CSF
1 ILHAN O 41 ANN AM SOC HEM M 1999 Vogelsang GB, Arai S Mycophenolate mofetil for the prevention and treatment of graft-versus-host disease following stem cell transplantation: preliminary findings
4 ILHAN O BLOOD 86 2055 1995
Peng J, Liu CF, Zhu KL, et al. The TNF2 allele is a risk factor to severe aplastic anemia independent of HLA-DR Oguz FS, Yalman N, Diler AS, et al. HLA-DRB1*15 and pediatric aplastic anemia Kapustin SI, Popova TI, Lyshchov AA, et al. HLA-DR4-Ala74 ss is associated with risk and poor outcome of severe aplastic anemia
1 ILHAN O BLOOD 1 S1 1 A958 1996
Ilhan O, Arslan O, Arat M, et al. The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation 1 ILHAN O HEMATOL CELL THER 39 133 1997 Tsang KS, Wong APY, Cheung MS, et al. Implication of maternal-cell contamination in the clinical banking of umbilical cord blood 1 ILHAN O INT J HEMATOL 66 291 1997 Oguz FS, Yalman N, Diler AS, et al. HLA-DRB1*15 and pediatric aplastic anemia 3 ILHAN O J CHEMOTHERAPY 9 56 1997
Priftakis P, Bogdanovic G, Kokhaei P, et al. BK virus (BKV) quantification in urine samples of bone marrow transplanted patients is helpful for diagnosis of hemorrhagic cystitis, although wide individual variations exist Deliliers GL, Annaloro C, Deliliers DL Complications of autologous hematopoietic stem cell transplantation Ordemann R, Naumann R, Geissler G, et al. Encouraging results in the treatment of haemorrhagic cystitis with estrogen - report of 10 cases and review of the literature
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
